Post 1/5
I'm a cardiologist. Let me tell you about the bravest and most reckless experiment in the history of medicine.
In 1984, a 32-year-old junior doctor in Australia walked into his hospital laboratory on a Tuesday morning, picked up a glass beaker containing one billion live bacteria suspended in beef broth, and drank it.
He told no one. Not his wife. Not his ethics committee. Not his hospital.
He had a theory that the entire global medical establishment had been treating one of the most common diseases on earth incorrectly for nearly a century.
He had run out of other ways to prove it.
His name was Barry Marshall. This is the story almost nobody tells you — and the reason I think about him every day in my own practice.
2/5 In 1979, a quiet pathologist named Robin Warren was looking at stomach biopsy slides at the Royal Perth Hospital when he noticed something impossible. Spiral-shaped bacteria, alive and active, living on the stomach lining.
Every textbook said the same thing: nothing survives in the stomach. Hydrochloric acid strong enough to dissolve metal. Bacteria could not colonize that environment. Every professor said so. Every pathologist who'd ever seen something strange on a slide had assumed contamination.
Warren kept looking. He kept finding them. For three years, almost no one in the hospital would listen.
In 1981, a 30-year-old trainee named Barry Marshall rotated through his department. They biopsied a hundred patients together. Every patient with a duodenal ulcer had the bacteria. Every single one.
Marshall presented the findings at the 1983 Royal Australian College of Physicians meeting. He proposed that these bacteria — later named Helicobacter pylori — caused most peptic ulcers. The disease the world had been calling a stress disorder for decades was an infection. Curable with two weeks of antibiotics.
The room laughed at him.
Senior gastroenterologists had built careers on the stress theory. The pharmaceutical industry had just launched H2 blockers — headed by Tagamet, soon to be the best-selling drug on earth. Acid-suppressing drugs would peak at $6 billion per year. Telling that industry their products treated the symptoms of an infection curable with $30 of antibiotics was professionally suicidal.
3/5 Marshall spent a year trying to prove the theory with animals. The bacteria refused to colonize rats. Refused pigs. It was so perfectly adapted to the human stomach that it wouldn't live anywhere else.
Without an animal model, the establishment had a perfect reason to keep dismissing him.
On July 12, 1984, at 10 AM, in the laboratory at Fremantle Hospital, Marshall had himself endoscoped first. His stomach was confirmed completely healthy. No bacteria. No inflammation. No disease.
Then he mixed a culture from a patient — one billion live organisms — into warm beef broth.
And he drank it.
He went home that evening and had dinner with his wife and four young children. He told no one.
Three days: nothing. Day four: bloating. Appetite gone. His mother visited and recoiled — his breath smelled like something had died inside him.
Day five: vomiting every morning at 6 AM. Clear liquid. No acid at all. The bacteria had colonized so successfully that they'd shut down his stomach's acid production — the very acid they supposedly couldn't survive in.
Day ten: a camera down his throat. His entire stomach lining was inflamed. Helicobacter pylori everywhere. Severe active gastritis. The exact disease pattern he'd been seeing in patients for three years.
He had given himself, in ten days, the disease the world said couldn't be caused by a bacterium.
He still hadn't told his wife.
She found out at dinner. Her response: "You idiot." She made him take antibiotics immediately.
4/5 The paper appeared in the Medical Journal of Australia in 1985. Three paragraphs. One subject. No control group. Against every modern principle of clinical research.
The medical world remained skeptical for another ten years.
During those ten years, patients across the globe continued to be told their ulcers were caused by stress. Continued to be prescribed acid-suppressing drugs indefinitely. Many progressed from ulcers to stomach cancer — the fifth most common cancer on earth — because nobody was treating the infection underneath.
H. pylori colonizes roughly half the human beings alive today. Most have never been tested.
Marshall has said the same thing in every interview since: the establishment didn't reject his theory because the evidence was weak. They rejected it because accepting it meant admitting they'd been treating patients incorrectly for a generation, and a multi-billion-dollar industry had been profiting from managing a curable infection.
The financial and reputational cost of being wrong was high enough that they preferred to assume the data was somehow wrong instead.
He won the Nobel Prize in 2005. Twenty-one years after the Tuesday morning with the beaker.
He was asked if he'd been scared. He said he wasn't scared of dying. He was scared of being right. He knew that if the experiment worked, the implication was that medicine had spent half a century misdiagnosing one of the most common diseases on earth. The easier outcome, professionally, was for the experiment to fail.
He was hoping it would fail.
He drank it anyway.
5/5 I think about Barry Marshall constantly.
Because I'm watching the same pattern in cardiology right now.
For decades, we told patients that heart disease was about cholesterol. Statins save lives — settled science. But patients kept having heart attacks with "perfect" numbers, and we kept treating the smoke while the fire burned underneath.
The fire is inflammation. The CANTOS trial proved that lowering inflammation independent of cholesterol reduces cardiac events. AI can now detect inflamed arteries on a CT scan. Low-dose colchicine — an ancient drug — is FDA-approved to quiet the inflammatory cascade that ruptures plaque. IL-6 inhibitors are in Phase 3 cardiovascular outcome trials right now.
The data is here. Just like Marshall's data was here in 1984.
And the gap between the data and the practice is where patients are still dying from conditions we now have the tools to prevent.
Protein misfolding linking heart failure to Alzheimer's — published today. Gut bacteria climbing the vagus nerve to trigger Parkinson's. Gum disease driving the same inflammation I treat in the cath lab. GLP-1 drugs reducing cancer metastasis by 50%.
Every one of these findings is telling us the same thing Marshall proved with a beaker of beef broth: the diseases we separated into different specialties share common roots. And the establishment will resist that truth for as long as the old model remains profitable and comfortable.
The most dangerous sentence in medicine has always been the same: "That's not how we do things."
Marshall drank a billion bacteria because the world wouldn't listen any other way.
You don't need to drink anything. You need to ask your doctor for an hsCRP test. Push for advanced cardiac imaging. Get your Lp(a) checked. Demand that "your numbers look fine" means ALL the numbers — not just the ones from a panel designed forty years ago.
The gap between data and acceptance is where people die from treatable conditions. Marshall proved that in 1984. The question is whether we'll learn faster this time.
I think we can. But only if patients stop accepting incomplete answers — and start asking the questions the science has already answered.
1/7 I have always adored Senator John Fetterman. In a Democratic Party that has descended into full-blown insanity and lunacy, he remains the one honest voice of sanity left standing. The last man who refuses to bow to the mob. While others sold their souls, Fetterman kept his. And that takes real courage.
2/7
The Democratic Party I once knew is gone. It has been captured by a radical coalition of Islamists, antisemitic socialists, and pro-Palestine extremists who openly cheer “from the river to the sea” and treat Hamas sympathizers as heroes. Fetterman has called this what it is: the “dirtbag left” having its “dancing days.” He said the party is becoming “an orgy of socialism” — and recent DSA primary victories in New York have proven him 100% right.
3/7 These aren’t fringe voices anymore. They’re winning. Candidates who cram the most anti-Israel, anti-America rhetoric into their platforms are defeating traditional Democrats. Fetterman warned us: the outlook for Jewish voters in this party is now “bleak.” Because anti-Zionism has become the new litmus test — and too many in the party look the other way or join in. He stands almost alone calling it antisemitism.
4/7
They want to take your wealth and destroy what makes America exceptional. Socialists don’t build. They seize. They punish success. They want to abolish borders, ICE, police, and prisons while calling it “justice.” Fetterman has blasted colleagues who refuse to call out this madness. America’s excellence — our innovation, our freedom, our capitalist engine that lifts the world — is under direct assault from within his own party. He refuses to pretend otherwise.
5/7 And then there’s the pro-Palestine insanity — personified by the “crazy” wing that embraced Kamala Harris. She pushed ceaselessly for ceasefires that would have left Hamas intact, called Trump a “fascist” (@JohnFetterman said she “lost the plot” on that one), and catered to the base that sees Israel as the villain and America as complicit. While Fetterman stood firm as Israel’s strongest Democratic defender, the party drifted toward those who question Israel’s right to exist as the Jewish state.
1/5 I'm a cardiologist. The same meal eaten at 8 AM and 8 PM does completely different things inside your body.
A Lancet-affiliated study just confirmed it: the time of day you've consumed 50% of your calories robustly predicts your insulin sensitivity, waist circumference, and metabolic health — independent of what or how much you eat.
Same food. Same amount. Different clock. Different outcome.
Most people eat their biggest meal at the exact hour their metabolism is least equipped to handle it.
2/5 Your insulin sensitivity peaks in the morning and declines throughout the day. The same plate of food your body handles cleanly at breakfast produces a dramatically larger insulin spike at dinner.
Glucose tolerance drops. Thermogenesis — calories burned processing food — falls. By evening, your pancreas works harder, blood sugar stays elevated longer, and your body shifts from burning to storing.
A 2025 RCT proved it experimentally: women eating within an early window lost significantly more weight while preserving muscle mass — not because they ate less. Because they ate earlier.
Your metabolism isn't broken. It's on the wrong schedule.
3/5 What I tell my patients — and follow myself:
Front-load your calories. Make breakfast or lunch your biggest meal. 40-50% of daily intake. Minimum 40g protein. Your body is primed to process it. Insulin response is clean. Thermogenesis is high.
Lighten dinner. Protein plus non-starchy vegetables. Fish, chicken, eggs, a big salad. Minimal starch. Stop asking your pancreas to do heavy work during the shift it's least capable.
Stop eating 3 hours before bed. Late eating spikes insulin when sensitivity is lowest AND disrupts the deep sleep phases when your body repairs, clears brain toxins, and produces testosterone.
Walk 10-15 minutes after your biggest meal. Blunts glucose spikes. Free. Available to everyone. Published repeatedly.
I'm a cardiologist. Let me tell you about the most extraordinary act of patient agency I've ever encountered.
In 2024, a tech founder named Sid Sijbrandij was told by his oncologists that they had nothing left. His osteosarcoma — an aggressive bone cancer in his spine — had returned after surgery, radiation, and chemotherapy so brutal he needed four blood transfusions to survive it. He'd exhausted every standard treatment. He wouldn't qualify for clinical trials. The implicit message: good luck.
Most people accept that verdict. Sijbrandij — co-founder of GitLab, a company worth $6.4 billion built on the principle that information should be open and transparent — decided to treat his cancer the way he'd built his company.
He went founder mode.
He quit his day job. Assembled a dream team. Hired a geneticist named Jacob Stern, formerly of 10x Genomics. And then he did something no cancer patient has ever done at this scale.
He generated 25 terabytes of his own medical data.
Whole genome sequencing. Whole exome sequencing. Bulk RNA-seq. Single-cell RNA-seq across multiple timepoints. Full-body PET/CT scans. Organoid models grown from his own tumor tissue. Immunohistochemistry. Spatial transcriptomics. Every diagnostic modality that exists — run on his specific cancer, at his specific stage, from his specific body.
Then Jacob Stern fed it all to ChatGPT
Not as a doctor. As what he called an "Iron Man suit" — an AI research partner that could synthesize 25 terabytes of genomic, imaging, and clinical data faster than any team of bioinformaticians. The AI identified patterns, surfaced relevant literature, generated hypotheses, and helped design therapeutic strategies that Sijbrandij's oncology team hadn't considered.
It identified a target called PANX3 — a protein highly expressed in his tumor but nearly absent in normal tissue. Exactly the kind of molecular fingerprint that makes precision therapy possible.
Then came the treatment cascade that reads like a medical thriller.
Sijbrandij filed five individual patient Investigational New Drug applications with the FDA. All five were approved within 48 hours. He flew to Germany for FAP radioligand therapy — a targeted radiation treatment that seeks out fibroblast markers his single-cell analysis had confirmed were dominant in his tumor. He received a checkpoint inhibitor to unleash his immune system. A personalized neoantigen peptide vaccine designed from his tumor's specific mutations. An oncolytic virus — a modified virus that infects and destroys cancer cells.
All of this — simultaneously — guided by AI-assisted analysis of his own data.
Before the combination therapy, only 19% of immune cells infiltrating his tumor site were T cells. After treatment: 89%. His immune system, long suppressed by the cancer, had come roaring back.
The tumor shrank enough for surgery at Memorial Sloan Kettering in April 2025. Surgeons removed what remained.
By June 2025: no evidence of disease. As of early 2026: still no evidence of disease.
He is now receiving a personalized mRNA neoantigen vaccine — custom-built from his tumor's unique mutations — to sustain the immune response. As backup, his team is developing personalized cell-based therapies equipped with genetic logic gates that trigger killing only when multiple cancer-specific signals are detected simultaneously.
His motto: "Stay paranoid."
And then he did the thing that transforms this from an extraordinary individual story into something that could change medicine.
He published everything.
The entire 25-terabyte dataset — genomic data, imaging, treatment protocols, outcomes — is publicly available at osteosarc.com. Free. Open access. So that any patient, any researcher, any physician facing a similar situation can build on what he learned.
True to the radical transparency that built GitLab. Applied to cancer.
He founded Even One Ventures to help scale personalized cancer treatment for patients who don't have a billion-dollar net worth. Because the uncomfortable truth in this story is also the most important: Sijbrandij is a billionaire. He could afford the experts, the flights to Germany, the experimental therapies, the FDA applications, the manufacturing.
He puts it bluntly: "It costs $1 billion to get a drug approved. It costs $1 million to dose one person with a personalized therapy."
The question isn't whether this works. It clearly can. The question is whether it becomes accessible — or remains the privilege of founders who can fund their own R&D.
I'm a cardiologist. A study published four days ago in Nature Medicine just proved something I've been trying to tell you on this platform for months: your body is aging faster than your parents' body did at the same age. And that accelerated aging is driving the cancer epidemic in younger adults.
WashU Medicine analyzed blood from over 164,000 people and found that those born in the 1990s show a biological age gap 92% larger than those born in the 1960s.
Same chronological age. Dramatically older biology.
And the people aging fastest had up to 15% higher risk of developing cancer before 55.
Here's the part that should change how you think about your next blood draw.
Here's the part that should change how you think about your next blood draw.
The researchers used an algorithm called PhenoAge that calculates your biological age from nine routine blood markers. Not exotic tests. Not expensive panels. Nine numbers you probably already have from your last physical:
Albumin — liver function.
Creatinine — kidney function.
Glucose — blood sugar.
C-reactive protein (hsCRP) — systemic inflammation.
Lymphocyte percentage — immune function.
Mean corpuscular volume — red blood cell size.
Red cell distribution width — red blood cell variation.
Alkaline phosphatase — liver and bone health.
White blood cell count — immune activity.
That's a basic metabolic panel plus a CBC plus hsCRP. Costs almost nothing. Available everywhere. You may already have these results sitting in your patient portal right now.
Free PhenoAge calculators exist online. Plug in your numbers and your actual age. The gap between the two tells you how fast your body is really aging.
Here's what the study found with those nine markers across 164,000 people.
Every standard deviation increase in biological age gap raised early-onset cancer risk by 8%. The fastest-aging group — the people whose bodies were running furthest ahead of their calendar years — had up to 15% higher cancer risk compared to the slowest agers. Even after accounting for genetics.
And the organ-specific findings are what connect this to everything I've been writing about.
I'm a cardiologist. Let me tell you what I see in my practice that breaks my heart more than any clogged artery.
A patient walks in carrying five diagnoses — obesity, high blood pressure, type 2 diabetes, fatty liver, and gout — on seven medications. Each prescribed by a different specialist. Each treating one symptom. None of them talking to each other.
Nobody told this patient the five diagnoses are one disease.
They are five faces of the same metabolic dysfunction. And the root is almost always the same: chronically elevated insulin driving fat storage, inflammation, and organ damage simultaneously.
Medicine gave this patient a bigger bucket under every leak instead of fixing the roof.
Here's the roof. And how to fix it.
In 2025, the ICD-10 coding system — the official classification used by every hospital and insurance company in America — added a new code: E11.A. Type 2 diabetes in remission. Medicine now officially recognizes that type 2 diabetes is not a permanent, progressive sentence. It can be reversed.
The DiRECT trial in the UK achieved 46% diabetes remission at one year through intensive dietary intervention. A 2025 Indian study of 2,384 patients achieved 31% remission. A 2024 trial in Pacific Islanders achieved 23% remission — with some patients entering remission without significant weight loss, proving the mechanism is metabolic, not just weight-driven.
This is not theoretical. It's published, replicated, and now coded in the medical system. Your doctor can document your reversal.
Here's the protocol I walk patients through — step by step.
𝗦𝘁𝗲𝗽 𝟭: 𝗥𝗲𝗺𝗼𝘃𝗲 𝘁𝗵𝗲 𝗶𝗻𝘀𝘂𝗹𝗶𝗻 𝗱𝗿𝗶𝘃𝗲𝗿𝘀.
For the first 30-60 days, eliminate the foods that spike insulin repeatedly throughout the day: added sugars, sugary drinks, refined carbohydrates (bread, pasta, rice, cereals, pastries), ultra-processed foods, and excess alcohol.
This isn't about calories. It's about insulin. Every spike locks fat inside fat cells, drives fat storage in the liver, raises blood pressure, elevates uric acid, and fuels systemic inflammation. Remove the constant trigger and your body stops being in defense mode.
Cravings peak around days 3-7 and then drop dramatically. Most patients report a clarity of mind by week two that they haven't felt in years.
𝗦𝘁𝗲𝗽 𝟮: 𝗥𝗲𝗯𝘂𝗶𝗹𝗱 𝘄𝗶𝘁𝗵 𝗿𝗲𝗮𝗹 𝗳𝗼𝗼𝗱.
Every meal: generous protein (30-50g), non-starchy vegetables (half the plate), healthy fats for satiety (olive oil, avocado, eggs, nuts, butter). Protein at every meal is non-negotiable — it stabilizes blood sugar, preserves muscle mass, and keeps you full for hours.
No calorie counting needed at the start. When you remove the processed foods that hijack appetite signaling, most people naturally eat less without trying — because their leptin and ghrelin systems start working properly again.
𝗦𝘁𝗲𝗽 𝟯: 𝗖𝗼𝗺𝗽𝗿𝗲𝘀𝘀 𝘆𝗼𝘂𝗿 𝗲𝗮𝘁𝗶𝗻𝗴 𝘄𝗶𝗻𝗱𝗼𝘄.
Two to three meals only. No grazing. No snacking. Eat within an 8-10 hour window — first meal around noon, last meal by 8 PM.
This gives your body long stretches in a low-insulin state — the fat-burning, liver-clearing, insulin-sensitizing mode that never activates when you eat six small meals throughout the day. Time-restricted eating improves insulin sensitivity independently of what you eat — published in multiple controlled trials.
Start at 12 hours. Shrink to 10. Then 8 when it feels natural. This is not deprivation — it's metabolic rest.
𝗦𝘁𝗲𝗽 𝟰: 𝗕𝘂𝗶𝗹𝗱 𝗺𝘂𝘀𝗰𝗹𝗲.
Muscle is the largest glucose disposal organ in your body. It is your metabolic insurance policy. A 2025 meta-analysis confirmed that combined aerobic and resistance training improves body composition, lipid metabolism, glucose metabolism, and physical function in type 2 diabetes.
Minimum effective protocol: strength training 3 times per week — squats, push-ups, rows, deadlifts — plus 7,000-10,000 daily steps. A 10-15 minute walk after meals is especially powerful for blood sugar control — multiple studies show it significantly blunts post-meal glucose spikes.
Do this consistently and your body becomes a glucose-processing machine. Insulin sensitivity improves with every session.